Lactate dehydrogenase A is implicated in the pathogenesis of B‐cell lymphoma through regulation of the FER signaling pathway
BioFactors · 2024
DOI: 10.1002/biof.2053 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioFactors, 2024. Verfasst von Xiumei Feng und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The Second Hospital of Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Signal Transduction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Key Research and Development Program of Shandong Province, Natural Science Foundation of Shandong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Lactate dehydrogenase A (LDHA) is highly expressed in various tumors. However, the role of LDHA in the pathogenesis of B‐cell lymphoma remains unclear. Analysis of data from The Cancer Genome Atlas (TCGA) and Genotype‐Tissue Expression (GTEx) databases revealed an elevated LDHA expression in diffuse large B‐cell lymphoma (DLBC) tissues compared with normal tissues. Similarly, our results demonstrated a significant increase in LDHA expression in tumor tissues from the patients with B‐cell lymphoma compared with those with lymphadenitis. To further elucidate potential roles of LDHA in B‐cell lymphoma pathogenesis, we silenced LDHA in the Raji cells (a B‐cell lymphoma cell line) using shRNA techniques. Silencing LDHA led to reduced mitochondrial membrane integrity, adenosine triphosphate (ATP) production, glycolytic activity, cell viability and invasion. Notably, LDHA knockdown substantially suppressed in vivo growth of Raji cells and extended survival in mice bearing lymphoma (Raji cells). Moreover, proteomic analysis identified feline sarcoma‐related protein (FER) as a differential protein positively associated with LDHA expression. Treatment with E260, a FER inhibitor, significantly reduced the metabolism, proliferation and invasion of Raji cells. In summary, our findings highlight that LDHA plays multiple roles in B‐cell lymphoma pathogenesis via FER pathways, establishing LDHA/FER may as a potential therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, The Second Hospital of Shandong University, Jinan, China.
- Department of Hematology, Fourth People's Hospital of Jinan City, Jinan, China.
- Department of Hematology, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.
- Hematology Department, Linyi Central Hospital, Yishui, China.
- Department of Clinical Laboratory, The Second Hospital of Shandong University, Jinan, China.
- Department of Nursing, The Second Hospital of Shandong University, Jinan, China.
ORCID-Profile: Yang Jiang, Chengyun Zheng
Förderung
- Key Research and Development Program of Shandong Province
- Natural Science Foundation of Shandong Province
- National Natural Science Foundation of China
- Science and Technology Project of Jinan Municipal Health Commission
- Key Technology Research and Development Program of Shandong Province
Zitieren
APA
Feng, X., Ren, J., Zhang, X., Kong, D., Yin, L., Zhou, Q., Wang, S., Li, A., Guo, Y., Wang, Y., Feng, X., Wang, X., Niu, J., Jiang, Y., & Zheng, C. (2024). Lactate dehydrogenase A is implicated in the pathogenesis of B‐cell lymphoma through regulation of the FER signaling pathway. BioFactors. https://doi.org/10.1002/biof.2053
Vancouver
Feng X, Ren J, Zhang X, Kong D, Yin L, Zhou Q, et al. Lactate dehydrogenase A is implicated in the pathogenesis of B‐cell lymphoma through regulation of the FER signaling pathway. BioFactors. 2024. doi:10.1002/biof.2053
BibTeX
@article{Feng2024,
author = {Feng, Xiumei and Ren, Jing and Zhang, Xunqi and Kong, Dexiao and Yin, Linlin and Zhou, Qian and Wang, Shunye and Li, Ai and Guo, Yanan and Wang, Yongjing and Feng, Xiaoli and Wang, Xiaoyun and Niu, Jianhua and Jiang, Yang and Zheng, Chengyun},
title = {Lactate dehydrogenase A is implicated in the pathogenesis of B‐cell lymphoma through regulation of the FER signaling pathway},
journal = {BioFactors},
year = {2024},
doi = {10.1002/biof.2053}
}
EUVIMED